These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CpG-Recoding in Zika Virus Genome Causes Host-Age-Dependent Attenuation of Infection With Protection Against Lethal Heterologous Challenge in Mice. Trus I; Udenze D; Berube N; Wheler C; Martel MJ; Gerdts V; Karniychuk U Front Immunol; 2019; 10():3077. PubMed ID: 32038625 [TBL] [Abstract][Full Text] [Related]
3. Infection of Aedes albopictus Mosquito C6/36 Cells with the Teramoto T; Huang X; Armbruster PA; Padmanabhan R J Virol; 2019 Aug; 93(15):. PubMed ID: 31092581 [TBL] [Abstract][Full Text] [Related]
4. Does the Zinc Finger Antiviral Protein (ZAP) Shape the Evolution of Herpesvirus Genomes? Lin YT; Chau LF; Coutts H; Mahmoudi M; Drampa V; Lee CH; Brown A; Hughes DJ; Grey F Viruses; 2021 Sep; 13(9):. PubMed ID: 34578438 [TBL] [Abstract][Full Text] [Related]
5. The dinucleotide composition of the Zika virus genome is shaped by conflicting evolutionary pressures in mammalian hosts and mosquito vectors. Fros JJ; Visser I; Tang B; Yan K; Nakayama E; Visser TM; Koenraadt CJM; van Oers MM; Pijlman GP; Suhrbier A; Simmonds P PLoS Biol; 2021 Apr; 19(4):e3001201. PubMed ID: 33872300 [TBL] [Abstract][Full Text] [Related]
6. Specific genetic markers for detecting subtypes of dengue virus serotype-2 in isolates from the states of Oaxaca and Veracruz, Mexico. Gardella-Garcia CE; Perez-Ramirez G; Navarrete-Espinosa J; Cisneros A; Jimenez-Rojas F; Ramírez-Palacios LR; Rosado-Leon R; Camacho-Nuez M; Munoz Mde L BMC Microbiol; 2008 Jul; 8():117. PubMed ID: 18625078 [TBL] [Abstract][Full Text] [Related]
7. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination. Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369 [TBL] [Abstract][Full Text] [Related]
8. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes. Uno N; Ross TM J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445 [TBL] [Abstract][Full Text] [Related]
9. Vector competence of the Aedes aegypti population from Santiago Island, Cape Verde, to different serotypes of dengue virus. da Moura AJ; de Melo Santos MA; Oliveira CM; Guedes DR; de Carvalho-Leandro D; da Cruz Brito ML; Rocha HD; Gómez LF; Ayres CF Parasit Vectors; 2015 Feb; 8():114. PubMed ID: 25888847 [TBL] [Abstract][Full Text] [Related]
10. Extensive genomic recoding by codon-pair deoptimization selective for mammals is a flexible tool to generate attenuated vaccine candidates for dengue virus 2. Stauft CB; Song Y; Gorbatsevych O; Pantoja P; Rodriguez IV; Futcher B; Sariol CA; Wimmer E Virology; 2019 Nov; 537():237-245. PubMed ID: 31539771 [TBL] [Abstract][Full Text] [Related]
11. Plant Virus Genome Is Shaped by Specific Dinucleotide Restrictions That Influence Viral Infection. González de Prádena A; Sánchez Jimenez A; San León D; Simmonds P; García JA; Valli AA mBio; 2020 Feb; 11(1):. PubMed ID: 32071264 [TBL] [Abstract][Full Text] [Related]
12. Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination. Briggs CM; Smith KM; Piper A; Huitt E; Spears CJ; Quiles M; Ribeiro M; Thomas ME; Brown DT; Hernandez R J Virol; 2014 Jun; 88(12):6729-42. PubMed ID: 24696467 [TBL] [Abstract][Full Text] [Related]
13. Targeting of highly conserved Dengue virus sequences with anti-Dengue virus trans-splicing group I introns. Carter JR; Keith JH; Barde PV; Fraser TS; Fraser MJ BMC Mol Biol; 2010 Nov; 11():84. PubMed ID: 21078188 [TBL] [Abstract][Full Text] [Related]
14. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine. Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922 [TBL] [Abstract][Full Text] [Related]
15. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development. Elong Ngono A; Shresta S Front Immunol; 2019; 10():1316. PubMed ID: 31244855 [TBL] [Abstract][Full Text] [Related]
16. CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice. Zellweger RM; Tang WW; Eddy WE; King K; Sanchez MC; Shresta S J Virol; 2015 Jun; 89(12):6494-505. PubMed ID: 25855749 [TBL] [Abstract][Full Text] [Related]
17. Recombinant vesicular stomatitis virus-based dengue-2 vaccine candidate induces humoral response and protects mice against lethal infection. Lauretti F; Chattopadhyay A; de Oliveira França RF; Castro-Jorge L; Rose J; Fonseca BA Hum Vaccin Immunother; 2016 Sep; 12(9):2327-33. PubMed ID: 27185081 [TBL] [Abstract][Full Text] [Related]
18. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection. Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881 [TBL] [Abstract][Full Text] [Related]
19. CpG Dinucleotides Inhibit HIV-1 Replication through Zinc Finger Antiviral Protein (ZAP)-Dependent and -Independent Mechanisms. Ficarelli M; Antzin-Anduetza I; Hugh-White R; Firth AE; Sertkaya H; Wilson H; Neil SJD; Schulz R; Swanson CM J Virol; 2020 Feb; 94(6):. PubMed ID: 31748389 [TBL] [Abstract][Full Text] [Related]
20. Dengue in Santander State, Colombia: fluctuations in the prevalence of virus serotypes are linked to dengue incidence and genetic diversity of the circulating viruses. Carreño MF; Jiménez-Silva CL; Rey-Caro LA; Conde-Ocazionez SA; Flechas-Alarcón MC; Velandia SA; Ocazionez RE Trop Med Int Health; 2019 Dec; 24(12):1400-1410. PubMed ID: 31596525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]